Underdiagnosed and undertreated, young Black males with ADHD get left behind

As a kid, Wesley Jackson Wade should have been set up to succeed. His father was a novelist and corporate sales director and his mother was a special education teacher.

ADA 2024: Altimmune’s GLP-1 drug shows weight loss potential – Pharmaceutical Technology

At the ADA scientific sessions, Altimmune presented data demonstrating significant weight loss in patients who took pemvidutide. Credit: Pavel Kapysh via Shutterstock. Altimmune has taken

June 24, 2024

BioNTech co-founder Özlem Türeci on ‘hip’ ADCs and the power of combo therapies

CHICAGO — Özlem Türeci took a seven-year break from attending the American Society of Clinical Oncology’s annual meeting. She’d been busy with the Covid-19 pandemic

June 6, 2024

Proposed PFAS rule would cost companies estimated $1B; lacks limits and cleanup requirement

A proposed federal rule calls for forcing companies to disclose whether their products contain toxic “forever” chemicals, the government’s first attempt at cataloging the pervasiveness

July 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.